60 mL BD® Syringe will now be 50mL

BD is making a change to the scale markings on all 50/60 mL BD® Syringes. Scale markings on all 60 mL BD® Syringes will no longer extend beyond 50 mL, and the product will be labeled and sold as a 50 mL BD® Syringe globally. There are no changes to device form, fit, function or raw material composition. … Continued

RMS Medical Products to Commence Trading on the NASDAQ

CHESTER, NY – October 14, 2019 – Repro Med Systems, Inc. dba RMS Medical Products (OTCQX: REPR) (“RMS Medical” or “the Company”) today announced that its common stock has been approved for listing and is expected to begin trading on the NASDAQ Capital Market on October 17, 2019 under the current symbol “REPR”. The Company’s … Continued

District Judge Issues Final Judgment in Favor of RMS Medical Products

CHESTER, NY – July 2, 2019 – Repro Med Systems, Inc. dba RMS Medical Products (OTCQX: REPR) (“RMS Medical” or “the Company”) today announced that on June 28, 2019 the United States District Judge for the Eastern District of Texas (Case No. 2:15-CV-01167-JRG-RSP) issued a Final Judgment in favor of RMS Medical in the Company’s … Continued

RMS Medical Products Appoints Craig S. Ross Vice President of Sales and Marketing

CHESTER, N.Y.–(BUSINESS WIRE)– Repro Med Systems, Inc. dba RMS Medical Products (OTCQX:REPR) (“RMS Medical”) today announced the appointment of Craig S. Ross as Vice President of Sales and Marketing, effective July 1, 2019. Mr. Ross brings to RMS Medical nearly 25 years of healthcare industry sales, marketing and leadership experience, including more than 20 years … Continued

RMS Appoints John Toomey as VP of Growth & Innovation

CHESTER, NY – June 14, 2019 – Repro Med Systems, Inc. dba RMS Medical Products (OTCQX: REPR) (“RMS Medical”) today announced the appointment of John Toomey to the newly created position of Vice President of Growth and Innovation. Mr. Toomey brings to RMS over 30 years of medical device industry experience as an executive, patent … Continued

RMS Medical Products Appoints Healthcare Industry Veteran R. John Fletcher to Board of Directors

Former Chairman of Spectranetics Corporation; NACD 2018 Director of the Year CHESTER, N.Y.–(BUSINESS WIRE)– Repro Med Systems, Inc. dba RMS Medical Products (OTCQX:REPR) (“RMS Medical”) announced that R. John Fletcher has been appointed as an independent member of RMS Medical’s Board of Directors. With this appointment, RMS Medical’s Board of Directors fills the vacancy created … Continued

RMS Gives PI Patients a Voice Through Social Media Campaign

Chester, NY – As April comes to a close, so does the 9th World Primary Immunodeficiency (PI) Week campaign, which took place April 22 – 29, 2019. April is also Primary Immunodeficiency Awareness Month. This years’ World PI Week theme put the spotlight on patient care. In our effort to help spread awareness, we (the … Continued

RMS Medical Products Announces Voting Results from Annual Meeting of Shareholders

Kathy S. Frommer Elected to the Board of Directors CHESTER, N.Y.–(BUSINESS WIRE)– Repro Med Systems, Inc. dba RMS Medical Products (OTCQX: REPR) (“RMS Medical”) today announced that shareholders voted in favor of all items of business put forth at the company’s Annual Meeting of Shareholders held on April 23, 2019 in Chester, NY. Shareholders elected director nominee … Continued

REPR 2018 Shareholders Meeting

Operating Highlights Record net revenues – up 12.4% Gross margin increased by 230 bps Higher income and Adjusted EBITDA Strong balance sheet with no debt and simple capital structure Refreshed and strengthened management team Added significant talent to the Board February 2019: strategic plan launched to become the preferred drug delivery partner for specific infusion … Continued